Multiplex Biomarker Techniques

Multiplex Technologies in COVID-19 Research, Diagnostics, and Prognostics: Battling the Pandemic.- Multivalent Vaccine Strategies in Battling the Emergence of COVID-19 Variants.- Challenges of Multiplex Assays for COVID-19 Research: A Machine Learning Perspective.- Multiplex Quantitative Polymerase Chain Reaction Diagnostic Test for SARS-CoV-2 and Influenza A/B Viruses.- Multiplex Quantitative Polymerase Chain Reaction Test to Identify SARS-CoV-2 Variants.- NIRVANA for Simultaneous Detection and Mutation Surveillance of SARS-CoV-2 and Co-Infections of Multiple Respiratory Viruses.- Quantitative Real-Time RT-PCR Systems to Detect SARS-CoV-2.- Guidance for SARS-CoV-2 RNA-Based Molecular Assay Analytical Performance Evaluations.- A Rapid User-Friendly Lab-on-a-Chip Microarray Platform for Detection of SARS-CoV-2 Variants.- SARS-CoV-2 Host Immunogenetic Biomarkers.- FnCas9 Editor Linked Uniform Detection Assay for COVID-19.- Mass Spectrometry Multiplexed Detection of SARS-CoV-2.- Identification of Circulating Biomarkers of COVID-19 Using MALDI-TOF Mass Spectrometry.- Antibody-Based Affinity Capture Combined with LC-MS Analysis for Identification of COVID-19 Disease Serum Biomarkers.- Liquid Chromatography Mass Spectrometry Analysis of Peripheral Blood Mononuclear Cells from SARS-CoV-2 Infected Patients.- Assay of Fatty Acids and Their Role in the Prevention and Treatment of COVID-19.- Lab-on-a-Chip Immunoassay for Prediction of Severe COVID-19 Disease.- Multiplex Immunoassay for Prediction of Disease Severity Associated with the Cytokine Storm in COVID-19 Cases.- Detection of IgG Antibodies to SARS-CoV-2 and Neutralizing Capabilities Using the Luminex® xMAP® SARS-CoV-2 Multi-Antigen IgG Assay.- Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases.- Evaluating the Effects of Curcumin on the Cytokine Storm in COVID-19 Using a Chip-Based Multiplex Analysis.- COVID-19 Detection Using the NHS Lateral Flow Test Kit.- Evaluation Protocol for